title: [Pharmacological strategies for clozapine-induced hypersalivation: treatment with botulinum toxin B in one patient and review of the literature].
authors.affiliation: Klinik für Psychiatrie und Psychotherapie, Universität Lübeck, 23538 Lübeck. kahl.k@psychiatry.uni-luebeck.de
authors.forename: K G
authors.initials: KG
authors.lastname: Kahl
authors.forename: P
authors.initials: P
authors.lastname: Trillenberg
authors.forename: A
authors.initials: A
authors.lastname: Kordon
authors.forename: R
authors.initials: R
authors.lastname: Lencer
authors.forename: C
authors.initials: C
authors.lastname: Klein
authors.forename: J
authors.initials: J
authors.lastname: Hagenah
mesh_terms: D000328:Adult; D001905:Botulinum Toxins / Q000008:administration & dosage*; D019274:Botulinum Toxins, Type A; D003024:Clozapine / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D008297:Male; D018727:Muscarinic Antagonists / Q000008:administration & dosage; D017410:Practice Guidelines as Topic; D010818:Practice Patterns, Physicians'; D012559:Schizophrenia / Q000150:complications / Q000188:drug therapy; D012798:Sialorrhea / Q000139:chemically induced* / Q000188:drug therapy*
chemical_list: D018727:Muscarinic Antagonists; C096323:rimabotulinumtoxinB; D001905:Botulinum Toxins; D019274:Botulinum Toxins, Type A; D003024:Clozapine
vernacular_title: Therapie der Clozapin-induzierten Hypersalivation mit Botulinum-Toxin B.